Available Forms: Tablets
Available Strengths: 50 mg
Reference Brands: Journavx(USA/EU)
Category: Neurology
Suzetrigine is a first-in-class non-opioid analgesic that selectively inhibits the NaV1.8 sodium channel in pain-sensing nerves. It is used for the management of moderate to severe acute pain in adults by reducing the transmission of pain signals from peripheral nerves to the central nervous system. Suzetrigine is available in Tablets and strengths such as 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Suzetrigine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Suzetrigine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Quick Response Guaranteed | Verified Suppliers
Suzetrigine is an anticonvulsant used to treat partial-onset seizures in patients with epilepsy. It helps stabilize neuronal activity in the brain and reduce seizure frequency.
It is made from the active ingredient suzetrigine, a synthetic compound that modulates voltage-gated sodium channels and calcium channels in the nervous system.
The trade name is Suzetrigine.
It is manufactured by regulatory-approved pharmaceutical companies that produce epilepsy medications; the exact manufacturer may vary by region.
The generic name is Suzetrigine.
The brand name is Suzetrigine.
It is manufactured in approved pharmaceutical production facilities depending on the manufacturer, typically in countries with regulatory approval for epilepsy drugs.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.